Foghorn Therapeutics to share preclinical cancer drug data at AACR meeting

April 9, 2026 7:01 AM

Foghorn Therapeutics Inc. (NASDAQ: FHTX) will present preclinical data for multiple drug programs at the 2026 American Association for Cancer ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found